Keyphrases
Mebendazole
100%
During Pregnancy
100%
Birth Outcomes
100%
National Cohort Study
100%
Anthelmintic
50%
Major Congenital Malformations
33%
Denmark
33%
Prescription Registry
16%
Indications for Treatment
16%
Maternal Exposure
16%
Trimester
16%
Logistic Regression Analysis
16%
Neonatal Mortality
16%
Common Infections
16%
Pinworm
16%
Congenital Malformations
16%
Small-for-gestational Age
16%
Adverse Pregnancy Outcomes
16%
Infections in children
16%
Stillbirth
16%
Potential Confounders
16%
Safety Data
16%
Soil-transmitted Helminths
16%
Medicine and Dentistry
Birth Outcomes
100%
Cohort Analysis
100%
Mebendazole
100%
Infection
66%
Antihelmintic
50%
Congenital Malformation
50%
Stillbirth
16%
Newborn Mortality
16%
Small for Gestational Age
16%
Maternal Exposure
16%
Logistic Regression Analysis
16%
Helminth
16%
Pharmacology, Toxicology and Pharmaceutical Science
Mebendazole
100%
Pyrvinium Embonate
100%
Cohort Study
100%
Infection
66%
Congenital Malformation
50%
Anthelmintic Agent
50%
Newborn Mortality
16%
Small for Date Infant
16%
Helminth
16%
Stillbirth
16%
Maternal Exposure
16%